Tailoring cancer therapy – Validating basic science with the ‘supertrial’

A paradigm shift in research culture is needed in order to set up the large ambitious trials needed to make personalised medicine a reality. Emma Wilkinson talks to the experts about the hurdles they face and what needs to change.